Goldman Sachs
CME icon

Goldman Sachs’s CME Group CME Stock Holding History

Goldman Sachs’s Portfolio CME Stock Details CME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.06B Buy
3,575,307
+341,273
+11% +$101M 0.12% 156
2025
Q4 		$883M Buy
3,234,034
+175,813
+6% +$47.8M 0.11% 158
2025
Q3 		$826M Buy
3,058,221
+205,505
+7% +$55.9M 0.1% 176
2025
Q2 		$786M Sell
2,852,716
-214,843
-7% -$58.4M 0.11% 173
2025
Q1 		$814M Sell
3,067,559
-42,317
-1% -$10.4M 0.13% 139
2024
Q4 		$722M Buy
3,109,876
+764,164
+33% +$176M 0.11% 149
2024
Q3 		$518M Sell
2,345,712
-351,902
-13% -$72.8M 0.08% 227
2024
Q2 		$530M Buy
2,697,614
+98,189
+4% +$20.3M 0.09% 213
2024
Q1 		$560M Buy
2,599,425
+249,338
+11% +$52.4M 0.1% 201
2023
Q4 		$495M Sell
2,350,087
-86,481
-4% -$18.5M 0.09% 212
2023
Q3 		$488M Sell
2,436,568
-64,685
-3% -$12.9M 0.1% 176
2023
Q2 		$463M Buy
2,501,253
+18,367
+0.7% +$3.39M 0.1% 179
2023
Q1 		$476M Buy
2,482,886
+446,166
+22% +$80.7M 0.11% 179
2022
Q4 		$342M Buy
2,036,720
+15,193
+0.8% +$2.64M 0.08% 237
2022
Q3 		$358M Buy
2,021,527
+680,159
+51% +$134M 0.09% 203
2022
Q2 		$275M Sell
1,341,368
-387,197
-22% -$82.1M 0.07% 285
2022
Q1 		$411M Buy
1,728,565
+38,756
+2% +$9.1M 0.09% 209
2021
Q4 		$386M Buy
1,689,809
+295,115
+21% +$64.9M 0.08% 252
2021
Q3 		$270M Buy
1,394,694
+26,805
+2% +$5.43M 0.06% 326
2021
Q2 		$291M Sell
1,367,889
-89,992
-6% -$19M 0.07% 287
2021
Q1 		$298M Sell
1,457,881
-880,244
-38% -$173M 0.08% 246
2020
Q4 		$426M Buy
2,338,125
+22,747
+1% +$3.87M 0.11% 165
2020
Q3 		$387M Sell
2,315,378
-56,141
-2% -$9.46M 0.11% 163
2020
Q2 		$385M Buy
2,371,519
+238,365
+11% +$42.7M 0.12% 156
2020
Q1 		$369M Buy
2,133,154
+232,586
+12% +$46.3M 0.13% 143
2019
Q4 		$381M Buy
1,900,568
+84,123
+5% +$17.3M 0.1% 211
2019
Q3 		$384M Sell
1,816,445
-189,730
-9% -$39.6M 0.11% 176
2019
Q2 		$389M Buy
2,006,175
+425,541
+27% +$78.4M 0.11% 170
2019
Q1 		$260M Sell
1,580,634
-242,772
-13% -$42.9M 0.08% 262
2018
Q4 		$343M Buy
1,823,406
+226,021
+14% +$41.7M 0.11% 164
2018
Q3 		$272M Sell
1,597,385
-254,500
-14% -$42.8M 0.07% 304
2018
Q2 		$304M Sell
1,851,885
-405,294
-18% -$66.2M 0.08% 237
2018
Q1 		$365M Buy
2,257,179
+288,479
+15% +$45.9M 0.09% 223
2017
Q4 		$288M Buy
1,968,700
+146,674
+8% +$20.9M 0.07% 316
2017
Q3 		$247M Sell
1,822,026
-98,356
-5% -$12.4M 0.06% 340
2017
Q2 		$241M Sell
1,920,382
-25,476
-1% -$3.05M 0.06% 329
2017
Q1 		$231M Sell
1,945,858
-210,085
-10% -$25.3M 0.06% 331
2016
Q4 		$249M Buy
2,155,943
+762,460
+55% +$84.8M 0.07% 306
2016
Q3 		$146M Buy
1,393,483
+148,061
+12% +$15.5M 0.04% 502
2016
Q2 		$121M Buy
1,245,422
+342,941
+38% +$32.4M 0.04% 557
2016
Q1 		$86.7M Sell
902,481
-23,989
-3% -$2.18M 0.03% 742
2015
Q4 		$83.9M Buy
926,470
+138,717
+18% +$13.1M 0.03% 764
2015
Q3 		$73.1M Buy
787,753
+101,823
+15% +$9.68M 0.02% 805
2015
Q2 		$63.8M Sell
685,930
-162,143
-19% -$15.1M 0.02% 941
2015
Q1 		$80.3M Sell
848,073
-160,423
-16% -$14.9M 0.03% 770
2014
Q4 		$89.4M Buy
1,008,496
+179,255
+22% +$15.2M 0.03% 728
2014
Q3 		$66.3M Sell
829,241
-207,243
-20% -$15.6M 0.02% 875
2014
Q2 		$73.5M Sell
1,036,484
-338,466
-25% -$23.8M 0.02% 857
2014
Q1 		$102M Sell
1,374,950
-358,140
-21% -$27M 0.03% 610
2013
Q4 		$136M Buy
1,733,090
+393,702
+29% +$30.8M 0.04% 485
2013
Q3 		$99M Buy
1,339,388
+16,506
+1% +$1.22M 0.04% 602
2013
Q2 		$100M Buy
+1,322,882
New +$86.8M 0.04% 549

Other funds holding CME

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Goldman Sachs's CME Position: Q1 2026 in Review

Goldman Sachs increased its CME Group (CME) stake by 11% in Q1 2026, buying an estimated $101M and bringing the position to 3,575,307 shares worth $1.06B. The position accounts for 0.12% of the portfolio, ranked #156.

Goldman Sachs first reported a position in CME in Q2 2013 and has held it in 52 quarters since. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • Goldman Sachs held 3,575,307 shares of CME Group worth $1.06B as of Q1 2026.
  • Goldman Sachs bought 341,273 CME Group shares in Q1 2026, an estimated $101M.
  • CME Group made up 0.12% of Goldman Sachs's portfolio in Q1 2026, its #156 holding.
  • Goldman Sachs first reported a position in CME Group in Q2 2013 and has held it in 52 quarters since.
  • 1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.